Email ID
Password
Sign me in automatically next time
08 September 2011

A new guidance on developing human cells for clinical applications is available 1 . The guidance was issued by the British Standards Institution , which says the document was written with an EU/US audience in mind and anticipates that it will be ...

02 August 2011

The Danish Medicines Agency has issued a list clarifying which clinical trial amendments will require approval by the DMA and which modifications can merely be notified to the agency 1 ,2 . The list has been issued in response to questions on the ...

02 August 2011

The Danish Medicines Agency has issued a list clarifying which clinical trial amendments will require approval by the DMA and which modifications can merely be notified to the agency 1 ,2 . The list has been issued in response to questions on the ...

08 September 2011

The US Food and Drug Administration has expressed concern over the protracted negotiations it is having with the medtech industry over reauthorising its medical device user fee programme, minutes from a 2 August meeting between the FDA and industry ...

08 September 2011

The US Food and Drug Administration is introducing two new training programmes to improve the consistency and skill of its medical device unit staff who review pre-market applications 1 . The programmes, designed for reviewers at the FDA?s Center ...

QSE
08 September 2011

A new guidance on developing human cells for clinical applications is available 1 . The guidance was issued by the British Standards Institution , which says the document was written with an EU/US audience in mind and anticipates that it will be ...

28 July 2011

Health Canada has developed a "pre-application package" to help companies involved in the importation, distribution or wholesale of drugs prepare for an initial good manufacturing practice inspection 1 . The package is intended to be used by ...

28 February 2011

The search functionality of Australia's online register of approved devices and drugs has been improved to enable industry, health professionals and consumers to find information on products more easily 1 ,2 . Changes to the Australian Register of ...

03 September 2009

US medtech industry association AdvaMed is concerned about the US Food and Drug Administration ?s draft guidance on presenting risk information while promoting medical products because it is too heavily focused on prescription drugs 1 . The guidance ...

 
27 April 2011
Ashley Yeo
With the US in mid-regulatory review, stakeholders are keenly pushing for a safer and faster system, but there are different views on how these goals should be achieved. That was shown at a hearing of the US Senate's Special Committee on Aging 1 . ...
 
23 July 2010
Amanda Maxwell
TÜV Product Service , one the main notified bodies for medical devices in the European Union, is in no doubt that the basic EU medtech regulatory ...
 
21 June 2011
Ellen Leinfuss discusses six key triggers that may attract an inspector's aggressive scrutiny of cGMP compliance and product quality. The US ...
21 June 2011
Maria Cianciotto outlines how companies can ensure they are prepared for inspections at all times. A cost-centre, a roadblock, a speed bump on the ...
23 February 2011
Stuart Walker, James Neil McAuslane and Lawrence Liberti report on progress by regulators and industry on the development of a common benefit-risk ...
 
08 October 2009
Please give details of the major acts and directives governing trademarks. Trademarks are governed in Luxembourg by the: Benelux Convention on ...
08 October 2009
Please give details of the major acts and directives governing trademarks. Trademarks are governed in Luxembourg by the: Benelux Convention on ...
 
RAJ Devices News Roundup, 11 December 2009
28 July 2011
 
 
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36